No results for ‘’
Medicamen Biotech Ltd
₹315
(1.01%)
Mon, 28 Sept 2026, 10:20 am
Health Technology
Pharmaceuticals: Major
24.5KMedicamen Biotech Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 40.46 | 40.46 | 40.46 | 40.46 | 43.16 |
| FII | 0.10 | 0.02 | 0.06 | 0.00 | 0.12 |
| DII | 0 | 0.44 | 0.59 | 0.64 | 0.69 |
| Public | 59.39 | 59.03 | 58.85 | 58.84 | 55.98 |
| Government | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
Medicamen Biotech Ltd Shareholding Pattern
The Medicamen Biotech Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Medicamen Biotech Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Medicamen Biotech Ltd (NSE: MEDICAMEQ, BSE: 531146) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Medicamen Biotech Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Medicamen Biotech Ltd Shareholding Pattern (Latest)
The latest Medicamen Biotech Ltd shareholding for Mar 2026 is:
- Promoters: 40.46%
- FII: 0.10%
- DII: 0%
- Public: 59.39%
- Government: 0.05%
Promoter holding in Medicamen Biotech Ltd remains stable, reflecting consistent long-term commitment.
Medicamen Biotech Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Medicamen Biotech Ltd.
- Mar 2026: 40.46%
- Dec 2025: 40.46%
- Sept 2025: 40.46%
- Jun 2025: 40.46%
- Mar 2025: 43.16%
Promoter stake remains largely stable, showing consistent ownership structure.
Medicamen Biotech Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Medicamen Biotech Ltd.
- Mar 2026: 0.10%
- Dec 2025: 0.02%
- Sept 2025: 0.06%
- Jun 2025: 0.00%
- Mar 2025: 0.12%
FII holding in Medicamen Biotech Ltd has increased recently, indicating rising foreign investor interest.
Medicamen Biotech Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0%
- Dec 2025: 0.44%
- Sept 2025: 0.59%
- Jun 2025: 0.64%
- Mar 2025: 0.69%
DII holdings remain stable, reflecting steady institutional participation.
Medicamen Biotech Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 59.39%
- Dec 2025: 59.03%
- Sept 2025: 58.85%
- Jun 2025: 58.84%
- Mar 2025: 55.98%
Public participation in Medicamen Biotech Ltd has increased, indicating rising retail investor interest.
Medicamen Biotech Ltd Government Holding
Government holding in Medicamen Biotech Ltd currently stands at 0.05%.
Government presence indicates institutional backing and regulatory confidence.
Medicamen Biotech Ltd Shareholding Analysis Summary
The Medicamen Biotech Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Medicamen Biotech Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Medicamen Biotech Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.